Bessemer Group
MYOK

Bessemer Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bessemer Group’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-23,148
Closed -$1.15M – 1929
2018
Q2 		$1.15M Hold
23,148
– – ﹤0.01% 542
2018
Q1 		$1.13M Buy
23,148
+11,870
+105% +$617K ﹤0.01% 556
2017
Q4 		$475K Sell
11,278
-12,800
-53% -$493K ﹤0.01% 824
2017
Q3 		$1.03M Buy
+24,078
New +$768K ﹤0.01% 647
2017
Q2 		– Sell
-10,275
Closed -$135K – 1953
2017
Q1 		$135K Buy
10,275
+1,447
+16% +$18.5K ﹤0.01% 1151
2016
Q4 		$114K Buy
+8,828
New +$136K ﹤0.01% 1203

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return